Early Breast Cancer Clinical Trials in Taipei
4 recruitingTaipei, Taiwan
Showing 1–4 of 4 trials
Recruiting
Phase 3
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Early Breast Cancer
Novartis Pharmaceuticals1,400 enrolled217 locationsNCT05827081
Recruiting
Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast Cancer (Early Breast Cancer)
AstraZeneca5,500 enrolled794 locationsNCT05952557
Recruiting
Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Breast Cancer (Early Breast Cancer)
AstraZeneca4,300 enrolled711 locationsNCT05774951
Recruiting
Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer
Early Breast CancerDuctal Breast Carcinoma In Situ
National Taiwan University Hospital315 enrolled2 locationsNCT06984250